Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Nanomedicine ; 21: 102062, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31344501

RESUMEN

Primary hepatocellular carcinoma (HCC) is a common malignant tumor. Surgery is the main treatment, but HCC patients have a potential risk of tumor recurrence. Besides, many limitations arise during the application of single first-line antitumor drugs. Here, we selected Pluronic F-127 and sodium alginate (SA) to prepare a thermosensitive gel (Gel). The optimal synergistic ratio of PTX and DOX on the SMMC-7721 cells was 1: 2 (w/w), calculated by the Chou-Talalay analysis. Then, PTX and DOX coloaded liposomes (PD-LPs) with such drugs ratios presented enhanced anticancer ability in vitro. Upon local injection, the PD-LPs Gel formed a nanoparticles reservoir at tumor via sol-gel transformation, while exhibiting a long-term effective anti-tumor ability in vivo. The relative tumor volume after the PD-LPs Gel treatment was reduced over 62%. Effective mitochondria related apoptosis induction was observed. Therefore, the local delivery of PD-LPs Gel can be a promising alternative method for the HCC therapy.


Asunto(s)
Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular , Doxorrubicina , Neoplasias Hepáticas Experimentales , Mitocondrias Hepáticas , Nanocompuestos , Animales , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Doxorrubicina/química , Doxorrubicina/farmacocinética , Doxorrubicina/farmacología , Humanos , Liposomas , Neoplasias Hepáticas Experimentales/tratamiento farmacológico , Neoplasias Hepáticas Experimentales/metabolismo , Neoplasias Hepáticas Experimentales/patología , Ratones , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/patología , Nanocompuestos/química , Nanocompuestos/uso terapéutico , Ensayos Antitumor por Modelo de Xenoinjerto
2.
Biochim Biophys Acta ; 1828(9): 2121-33, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23685124

RESUMEN

The cell-toxic bile salt glycochenodeoxycholic acid (GCDCA) and taurochenodeoxycholic acid (TCDCA) are responsible for hepatocyte demise in cholestatic liver diseases, while tauroursodeoxycholic acid (TUDCA) is regarded hepatoprotective. We demonstrate the direct mitochondrio-toxicity of bile salts which deplete the mitochondrial membrane potential and induce the mitochondrial permeability transition (MPT). The bile salt mediated mechanistic mode of destruction significantly differs from that of calcium, the prototype MPT inducer. Cell-toxic bile salts initially bind to the mitochondrial outer membrane. Subsequently, the structure of the inner boundary membrane disintegrates. And it is only thereafter that the MPT is induced. This progressive destruction occurs in a dose- and time-dependent way. We demonstrate that GCDCA and TCDCA, but not TUDCA, preferentially permeabilize liposomes containing the mitochondrial membrane protein ANT, a process resembling the MPT induction in whole mitochondria. This suggests that ANT is one decisive target for toxic bile salts. To our knowledge this is the first report unraveling the consecutive steps leading to mitochondrial destruction by cell-toxic bile salts.


Asunto(s)
Ácido Glicoquenodesoxicólico/toxicidad , Mitocondrias Hepáticas/efectos de los fármacos , Translocasas Mitocondriales de ADP y ATP/agonistas , Ácido Tauroquenodesoxicólico/farmacología , Animales , Permeabilidad de la Membrana Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Liposomas/química , Hígado/química , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias Cardíacas/química , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/patología , Translocasas Mitocondriales de ADP y ATP/aislamiento & purificación , Proteínas de Transporte de Membrana Mitocondrial/agonistas , Proteínas de Transporte de Membrana Mitocondrial/metabolismo , Membranas Mitocondriales/química , Membranas Mitocondriales/efectos de los fármacos , Poro de Transición de la Permeabilidad Mitocondrial , Miocardio/química , Ratas , Ácido Tauroquenodesoxicólico/toxicidad , Canales Aniónicos Dependientes del Voltaje/química , Canales Aniónicos Dependientes del Voltaje/aislamiento & purificación
3.
ACS Appl Mater Interfaces ; 11(43): 39574-39585, 2019 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-31589019

RESUMEN

In the past few decades, intracellular calcium overload has been shown to induce cell death through multiple signaling pathways. In this study, we used BAPTA-AM, a well-known membrane-permeable Ca2+ chelator, to prevent cell injury by allaying the intracellular calcium overload. We explored the clinical potentials of BAPTA-AM-loaded liposome (BAL) in the treatment of the acute liver failure (ALF) mouse model, which is characterized by severe hepatic necrosis and apoptosis. We discovered that BAL can significantly inhibit D-GalN-induced LO2 cell damage as it increased cell viability by 60% and downregulated the LPS-stimulated inflammatory response in RAW 264.7 macrophages by reversing the morphological change and modulating TNF-α and NF-κB expressions. Through systemic administration, BAL can rapidly accumulate in damaged liver tissue and exhibit excellent treatment effects on the D-GalN/LPS-induced ALF mouse model, including elevation of the survival rate (from 10 to 80%), recovery of normal liver indexes and liver health indicators, improvement of liver blood microcirculation (increased the blood flow volume by 80% and flow rate by 60%), and blood coagulation. The underlying hepatoprotective effect of BAL is presumably based on the antinecrosis and antiapoptosis abilities attributed to its inhibition on oxidative stress, restriction on TNF-α receptor, and mitochondria-mediated apoptotic pathway by effectively clearing the overloaded intercellular calcium. BAL holds great potential as a new therapeutic strategy for ALF treatment, and its prominent cell rescue ability provides ample opportunities for the treatment of many other diseases that are characterized by rapid and massive cell damage.


Asunto(s)
Apoptosis/efectos de los fármacos , Calcio/metabolismo , Ácido Egtácico/análogos & derivados , Fallo Hepático Agudo , Animales , Ácido Egtácico/química , Ácido Egtácico/farmacología , Lipopolisacáridos/toxicidad , Liposomas , Fallo Hepático Agudo/inducido químicamente , Fallo Hepático Agudo/tratamiento farmacológico , Fallo Hepático Agudo/metabolismo , Fallo Hepático Agudo/patología , Ratones , Ratones Endogámicos ICR , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/patología , FN-kappa B/metabolismo , Células RAW 264.7 , Factor de Necrosis Tumoral alfa/metabolismo
4.
Biomed Res Int ; 2015: 794287, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26543868

RESUMEN

Ischemia reperfusion injury (IRI) leads to significant tissue damage in liver surgery. Polyethylene glycols (PEGs) are water soluble nontoxic polymers that have proved their effectiveness against IRI. The objective of our study was to investigate the potential protective effects of intravenous administration of a high molecular weight PEG of 35 kDa (PEG 35) in steatotic livers subjected to cold ischemia reperfusion. In this study, we used isolated perfused rat liver model to assess the effects of PEG 35 intravenous administration after prolonged cold ischemia (24 h, 4°C) and after reperfusion (2 h, 37°C). Liver injury was measured by transaminases levels and mitochondrial damage was determined by confocal microscopy assessing mitochondrial polarization (after cold storage) and by measuring glutamate dehydrogenase activity (after reperfusion). Also, cell signaling pathways involved in the physiopathology of IRI were assessed by western blot technique. Our results show that intravenous administration of PEG 35 at 10 mg/kg ameliorated liver injury and protected the mitochondria. Moreover, PEG 35 administration induced a significant phosphorylation of prosurvival protein kinase B (Akt) and activation of cytoprotective factors e-NOS and AMPK. In conclusion, intravenous PEG 35 efficiently protects steatotic livers exposed to cold IRI.


Asunto(s)
Hígado Graso/tratamiento farmacológico , Mitocondrias Hepáticas/patología , Polietilenglicoles/administración & dosificación , Daño por Reperfusión/tratamiento farmacológico , Administración Intravenosa , Animales , Isquemia Fría , Modelos Animales de Enfermedad , Hígado Graso/metabolismo , Hígado Graso/fisiopatología , Humanos , Mitocondrias Hepáticas/ultraestructura , Peso Molecular , Ratas , Daño por Reperfusión/fisiopatología , Transaminasas/metabolismo
5.
World J Gastroenterol ; 20(43): 16203-14, 2014 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-25473175

RESUMEN

AIM: To test whether a new rinse solution containing polyethylene glycol 35 (PEG-35) could prevent ischemia-reperfusion injury (IRI) in liver grafts. METHODS: Sprague-Dawley rat livers were stored in University of Wisconsin preservation solution and then washed with different rinse solutions (Ringer's lactate solution and a new rinse solution enriched with PEG-35 at either 1 or 5 g/L) before ex vivo perfusion with Krebs-Heinseleit buffer solution. We assessed the following: liver injury (transaminase levels), mitochondrial damage (glutamate dehydrogenase activity), liver function (bile output and vascular resistance), oxidative stress (malondialdehyde), nitric oxide, liver autophagy (Beclin-1 and LCB3) and cytoskeleton integrity (filament and globular actin fraction); as well as levels of metalloproteinases (MMP2 and MMP9), adenosine monophosphate-activated protein kinase (AMPK), heat shock protein 70 (HSP70) and heme oxygenase 1 (HO-1). RESULTS: When we used the PEG-35 rinse solution, reduced hepatic injury and improved liver function were noted after reperfusion. The PEG-35 rinse solution prevented oxidative stress, mitochondrial damage, and liver autophagy. Further, it increased the expression of cytoprotective heat shock proteins such as HO-1 and HSP70, activated AMPK, and contributed to the restoration of cytoskeleton integrity after IRI. CONCLUSION: Using the rinse solution containing PEG-35 was effective for decreasing liver graft vulnerability to IRI.


Asunto(s)
Isquemia Fría , Hígado/irrigación sanguínea , Hígado/efectos de los fármacos , Soluciones Preservantes de Órganos/farmacología , Preservación de Órganos/métodos , Polietilenglicoles/farmacología , Daño por Reperfusión/prevención & control , Adenosina/farmacología , Alopurinol/farmacología , Animales , Autofagia/efectos de los fármacos , Biomarcadores/metabolismo , Citoprotección , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Citoesqueleto/patología , Modelos Animales de Enfermedad , Glutatión/farmacología , Hepatectomía , Insulina/farmacología , Hígado/metabolismo , Hígado/patología , Pruebas de Función Hepática , Masculino , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/patología , Estrés Oxidativo/efectos de los fármacos , Rafinosa/farmacología , Ratas Sprague-Dawley , Daño por Reperfusión/etiología , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Transducción de Señal/efectos de los fármacos , Factores de Tiempo
7.
Biull Eksp Biol Med ; 112(8): 135-6, 1991 Aug.
Artículo en Ruso | MEDLINE | ID: mdl-1838489

RESUMEN

The influence of multibilayer phosphatidylcholine liposomes on the properties of rat hepatocyte mitochondria membranes damages caused by hepatotropic toxin--CCl4 was investigated. Alterations of the membrane structure were estimated by the decrease in phospholipid/protein ratio /by 33%/ and via changes of quantitative and qualitative composition of phospholipid components. The possibility of reparation of the hepatocytes mitochondria damaged membrane by egg yolk phosphatidylcholine liposomes is shown. Phosphatidylcholine reparative effect on the damaged membranes is revealed in quantitative phospholipid fractions redistribution.


Asunto(s)
Mitocondrias Hepáticas/efectos de los fármacos , Fosfatidilcolinas/farmacología , Adenosina Trifosfatasas/metabolismo , Animales , Intoxicación por Tetracloruro de Carbono/patología , Portadores de Fármacos , Liposomas , Regeneración Hepática , Masculino , Mitocondrias Hepáticas/enzimología , Mitocondrias Hepáticas/patología , Fosfatidilcolinas/administración & dosificación , Ratas
8.
Rocz Akad Med Bialymst ; 49 Suppl 1: 180-1, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15638415

RESUMEN

The aim of the experiment was to determine the effect of fluoride on ultrastructural changes in the submandibular gland, the pancreas and the liver. The experimental rats received fluoride in aqueous solutions of sodium fluoride at concentrations of 10.6 NaF/dm3 and 32.0 NaF/dm3. In the ultrastructural examination, mitochondria were most damaged.


Asunto(s)
Mitocondrias Hepáticas/patología , Mitocondrias/patología , Páncreas/patología , Fluoruro de Sodio/toxicidad , Glándula Submandibular/patología , Animales , Femenino , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/ultraestructura , Páncreas/efectos de los fármacos , Ratas , Glándula Submandibular/efectos de los fármacos , Abastecimiento de Agua
9.
Biochemistry ; 43(39): 12592-605, 2004 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-15449949

RESUMEN

Sterol carrier protein-2 (SCP-2) facilitates cholesterol (Ch) and phospholipid (PL) transfer/exchange between membranes and appears to play a key role in intracellular lipid trafficking. Whether SCP-2 can also facilitate lipid hydroperoxide (LOOH) transfer between membranes and thereby potentially enhance dissemination of peroxidative damage was examined in this study. Transfer kinetics of photochemically generated cholesterol hydroperoxide (ChOOH) species (5alpha-OOH, 6alpha/6beta-OOH, 7alpha/7beta-OOH) and phospholipid hydroperoxide (PLOOH) families (PCOOH, PEOOH, PSOOH) were determined, using HPLC with electrochemical detection for peroxide analysis. LOOH donor/acceptor pairs employed in transfer experiments included (i) all liposomes (e.g., agglutinable SUVs/ nonagglutinable LUVs); (ii) photoperoxidized erythrocyte ghosts/SUVs or vice versa; and (iii) SUVs/mitochondria. In a SUV/ghost system at 37 degrees C, the rate constant for total ChOOH spontaneous transfer was approximately 8 times greater than that for unoxidized Ch. Purified bovine liver and human recombinant SCP-2 exhibited an identical ability to stimulate overall ChOOH transfer, 0.5 unit/mL (based on [(14)C]Ch transfer) increasing the first-order rate constant (k) approximately 7-fold. SCP-2-enhanced translocation of individual ChOOHs increased with increasing hydrophilicity in the following order: 6beta-OOH < 6alpha-OOH < 5alpha-OOH < 7alpha/7beta-OOH. Likewise, SCP-2 stimulated PCOOH, PEOOH, or PSOOH transfer approximately 6-fold, but the net k was 1/5 that of 5alpha-OOH and 1/10 that of 7alpha/7beta-OOH. Donor membrane properties favoring SCP-2-enhanced LOOH transfer included (i) increasing PL unsaturation and (ii) increasing net negative charge imposed by phosphatidylserine. Cytotoxic relevance was demonstrated by showing that SCP-2 accelerates 7alpha-OOH transfer from SUVs to isolated mitochondria and that this enhances peroxide-induced loss of the mitochondrial membrane potential. On the basis of these findings, we postulate that SCP-2, by trafficking ChOOHs and PLOOHs in addition to parent lipids, might exacerbate cell injury under oxidative stress conditions.


Asunto(s)
Proteínas Portadoras/química , Proteínas Portadoras/metabolismo , Colesterol/metabolismo , Membranas Intracelulares/metabolismo , Peróxidos Lipídicos/metabolismo , Fosfolípidos/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Portadoras/toxicidad , Bovinos , Colesterol/química , Membrana Eritrocítica/química , Membrana Eritrocítica/metabolismo , Membrana Eritrocítica/patología , Humanos , Membranas Intracelulares/química , Membranas Intracelulares/patología , Peroxidación de Lípido , Peróxidos Lipídicos/química , Liposomas , Potenciales de la Membrana , Ratones , Mitocondrias Hepáticas/química , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/patología , Datos de Secuencia Molecular , Fosfolípidos/química , Transporte de Proteínas , Electricidad Estática
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA